From: T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients
Details | Number |
---|---|
Number of patients | 18 |
Male (%) | 15 (83) |
Age ± SD (years) | 58 ± 10 |
Hypertension (%) | 5 (28) |
Smoking (%) | 9 (50) |
Dyslipidemia (%) | 3 (17) |
Chest pain onset to balloon time (minutes) | 292 (116–800) |
Infarct artery and location (%) | Â |
LAD | 12 (67) |
Proximal/ Mid/ Distal | 5 (42)/6 (50)/1 (8) |
RCA | 6 (33) |
Proximal/ Mid/ Distal | 3 (50)/2 (33)/1(17) |
Pre-PPCI TIMI flow (%) | Â |
0/1/2/3 | 13 (72)/4 (22)/1 (6)/0 (0) |
Post-PPCI TIMI flow (%) | Â |
0/1/2/3 | 1 (6)/0 (0)/2 (12)/15 (82) |
Single vessel disease | 13 (72) |
Double vessel disease | 5 (28) |
Days from PPCI to CMR | 5 (4–6) |
Left ventricular ejection fraction (%) | 49 ± 11 (Normal range 58–76) |
End diastolic volume (ml) | 135 ± 21 (Normal range 113–196) |
Left ventricular mass (g) | 151 ± 50 (Normal range 107–184) |
Presence of MVO (%) | 8 (44) |
Infarct size by LGE, (% LV volume) | 18.8 ± 9.4 |
AAR by T1-mapping, (% LV volume) | 32.3 ± 11.5 |
AAR by T2-mapping, (% LV volume) | 31.6 ± 11.2 |